PODD

260.68

0.22% 0.56

Handel nachbörslich: 260.68

Insulet Corporation (PODD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PODD? Forum Prognose

Schlusskurs vom Vortag:

$260.12

Offen:

$260.1

24-Stunden-Volumen:

668.71K

Relative Volume:

1.08

Marktkapitalisierung:

$18.29B

Einnahmen:

$1.87B

Nettoeinkommen (Verlust:

$395.30M

KGV:

152.44

EPS:

1.71

Netto-Cashflow:

$182.40M

1W Leistung:

-5.45%

1M Leistung:

+10.18%

6M Leistung:

+39.20%

1J Leistung:

+49.76%

1-Tages-Spanne:

$260.01

$263.93

1-Wochen-Bereich:

$257.43

$276.57

52-Wochen-Spanne:

$160.19

$279.40

Insulet Corporation Stock (PODD) Company Profile

Firmenname

Insulet Corporation

Sektor

Healthcare (1196)

Branche

Medical Devices (153)

Telefon

978-600-7000

Adresse

100 NAGOG PARK, ACTON, MA

Mitarbeiter

3,000

Twitter

@insulet_uk

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PODD's Discussions on Twitter

Vergleichen Sie PODD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PODD	260.68	18.29B	1.87B	395.30M	182.40M	1.71
ABT	117.36	202.64B	41.22B	5.77B	6.49B	2.94
SYK	389.40	150.72B	21.97B	3.59B	3.21B	6.74
BSX	90.45	133.82B	15.91B	1.79B	1.89B	0.82
MDT	87.59	112.98B	32.58B	3.93B	5.15B	2.71
EW	69.89	40.52B	6.60B	4.16B	490.10M	2.34

Insulet Corporation Stock (PODD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-21	Hochstufung	Robert W. Baird	Neutral → Outperform
2023-12-04	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-10-02	Hochstufung	Jefferies	Hold → Buy
2023-08-21	Hochstufung	Citigroup	Neutral → Buy
2023-08-21	Herabstufung	Robert W. Baird	Outperform → Neutral
2023-05-30	Fortgesetzt	Morgan Stanley	Equal-Weight
2023-01-26	Eingeleitet	Wolfe Research	Peer Perform
2022-11-04	Hochstufung	Piper Sandler	Neutral → Overweight
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-12	Eingeleitet	Jefferies	Hold
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-02-03	Hochstufung	BTIG Research	Neutral → Buy
2022-02-02	Hochstufung	UBS	Neutral → Buy
2022-01-31	Hochstufung	Oppenheimer	Perform → Outperform
2021-07-21	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-01	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2021-03-19	Hochstufung	Canaccord Genuity	Hold → Buy
2021-01-29	Herabstufung	Piper Sandler	Overweight → Neutral
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-07-28	Eingeleitet	Wells Fargo	Overweight
2020-04-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-04-03	Eingeleitet	BofA/Merrill	Neutral
2020-03-31	Herabstufung	Berenberg	Buy → Hold
2020-03-05	Eingeleitet	Citigroup	Buy
2019-12-10	Eingeleitet	CFRA	Sell
2019-10-23	Eingeleitet	Stifel	Hold
2019-10-18	Herabstufung	Canaccord Genuity	Buy → Hold
2019-10-14	Herabstufung	BTIG Research	Buy → Neutral
2019-10-04	Herabstufung	UBS	Buy → Neutral
2019-10-03	Herabstufung	Guggenheim	Buy → Neutral
2019-08-06	Hochstufung	JP Morgan	Neutral → Overweight
2019-06-10	Herabstufung	Northland Capital	Outperform → Market Perform
2019-05-06	Hochstufung	BTIG Research	Neutral → Buy
2018-04-20	Eingeleitet	Berenberg	Buy
2018-02-22	Bestätigt	Barclays	Overweight
2018-01-08	Hochstufung	Raymond James	Mkt Perform → Outperform
2017-11-03	Hochstufung	Canaccord Genuity	Hold → Buy
2017-09-15	Eingeleitet	Barclays	Overweight

Alle ansehen

Insulet Corporation Aktie (PODD) Neueste Nachrichten

Nov 17, 2024

Insulet Co. (NASDAQ:PODD) Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat

Nov 17, 2024

Nov 16, 2024

Insulet Corp - Cyber Magazine

Nov 16, 2024

Mizuho Securities USA LLC Has $75.84 Million Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 16, 2024

Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals - Yahoo Finance

Nov 16, 2024

GSA Capital Partners LLP Acquires Shares of 4,370 Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Commit To Buy Insulet At $260, Earn 15.4% Annualized Using Options - Nasdaq

Nov 15, 2024

Insulet to Present at Major Healthcare Conferences, Showcasing Omnipod 5 Innovation | PODD Stock News - StockTitan

Nov 15, 2024

Nov 14, 2024

William Blair Has Optimistic Outlook of Insulet Q3 Earnings - MarketBeat

Nov 14, 2024

Principal Financial Group Inc. Grows Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Insulet corp director Luciana Borio sells $139,598 in stock - Investing.com

Nov 13, 2024

Insulet corp director Luciana Borio sells $139,598 in stock By Investing.com - Investing.com Australia

Nov 13, 2024

Insider Sale: Director Luciana Borio Sells Shares of Insulet Cor - GuruFocus.com

Nov 13, 2024

William Blair Issues Optimistic Outlook for Insulet Earnings - MarketBeat

Nov 13, 2024

Los Angeles Capital Management LLC Has $3.24 Million Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 13, 2024

Capital Research Global Investors Expands Stake in Insulet Corp - GuruFocus.com

Nov 13, 2024

Insulet's SWOT analysis: diabetes tech leader faces competition in pump market - Investing.com

Nov 13, 2024

Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Insulet Corporation Rings the Closing Bell - Nasdaq

Nov 12, 2024

Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More - Yahoo Finance Australia

Nov 12, 2024

Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance

Nov 12, 2024

Insulet Co. (NASDAQ:PODD) Shares Bought by Baillie Gifford & Co. - MarketBeat

Nov 12, 2024

PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up - Yahoo Finance

Nov 12, 2024

Insulet price target raised to $317 from $234 at Morgan Stanley - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

Barclays raises Insulet stock price target following robust Q3 beat By Investing.com - Investing.com Canada

Nov 11, 2024

Barclays raises Insulet stock price target following robust Q3 beat - Investing.com India

Nov 11, 2024

Barclays Increases Insulet (NASDAQ:PODD) Price Target to $234.00 - MarketBeat

Nov 11, 2024

Morgan Stanley Raises Insulet (NASDAQ:PODD) Price Target to $317.00 - MarketBeat

Nov 11, 2024

Ownership Capital B.V. Decreases Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 10, 2024

Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance

Nov 10, 2024

Nov 09, 2024

Insulet (NASDAQ:PODD) Shares Up 10.7% After Analyst Upgrade - MarketBeat

Nov 09, 2024

Insulet Corporation (NASDAQ:PODD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Insulet Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 09, 2024

AEGON ASSET MANAGEMENT UK Plc Has $31.51 Million Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 09, 2024

Robeco Institutional Asset Management B.V. Cuts Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 09, 2024

Nov 08, 2024

Earnings call: Insulet Corporation touts strong Q3 growth and type 2 expansion - Investing.com

Nov 08, 2024

Insulet (NASDAQ:PODD) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat

Nov 08, 2024